Rallis India Limited (BOM:500355)

CTI BioPharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	71,399	41,671	48,714	37,513	46,293	49,162
Market Cap Growth	3.88%	-14.46%	29.86%	-18.97%	-5.83%	43.88%
Enterprise Value	67,657	40,061	48,734	38,667	44,368	45,016
Last Close Price	367.00	212.93	246.19	186.97	227.31	239.39
PE Ratio	41.48	33.30	32.94	40.80	28.19	21.51
PS Ratio	2.52	1.57	1.84	1.26	1.78	2.02
PB Ratio	3.75	2.19	2.66	2.17	2.73	3.09
P/TBV Ratio	4.32	2.52	3.11	2.56	3.27	3.71
P/FCF Ratio	-	18.31	24.48	79.11	478.87	66.49
P/OCF Ratio	-	14.12	18.11	17.30	27.92	22.69
EV/Sales Ratio	2.38	1.50	1.84	1.30	1.70	1.85
EV/EBITDA Ratio	19.47	14.75	16.29	15.69	16.02	14.21
EV/EBIT Ratio	29.03	22.62	23.28	22.19	20.20	16.74
EV/FCF Ratio	-	17.60	24.49	81.54	458.95	60.88
Debt / Equity Ratio	0.03	0.03	0.07	0.08	0.06	0.05
Debt / EBITDA Ratio	0.18	0.22	0.42	0.52	0.32	0.23
Debt / FCF Ratio	-	0.28	0.67	2.88	9.59	1.02
Asset Turnover	-	0.89	0.91	1.05	0.96	0.97
Inventory Turnover	-	1.92	1.88	2.17	1.85	1.95
Quick Ratio	-	1.05	0.86	0.80	0.72	0.87
Current Ratio	-	1.93	1.75	1.66	1.67	1.81
Return on Equity (ROE)	-	6.70%	8.31%	5.37%	9.99%	15.23%
Return on Assets (ROA)	-	3.70%	4.51%	3.85%	5.04%	6.67%
Return on Capital (ROIC)	7.41%	5.63%	6.83%	5.96%	7.94%	10.60%
Return on Capital Employed (ROCE)	-	8.80%	10.50%	9.60%	12.30%	16.10%
Earnings Yield	2.41%	3.00%	3.03%	2.45%	3.55%	4.65%
FCF Yield	-	5.46%	4.08%	1.26%	0.21%	1.50%
Dividend Yield	0.70%	1.17%	1.01%	1.34%	1.32%	1.25%
Payout Ratio	-	38.80%	32.81%	63.53%	35.63%	21.34%
Total Shareholder Return	1.05%	1.17%	1.01%	1.34%	1.32%	1.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.